Introduction
It has been known for years that the routine determination of creatinine in serum can present laboratory workers with serious problems.
The traditipnally used methods are all based on the well known Jaffe reaction (1) . In spite of the many modifications of this method, interference by one or m re s bstances still exists. A comprehensive list is given by Young et aL (2) .
We met this problem in pur laboratory after the introduction of the Technicon Chem l analyser. Clinicians criticized the value of some creatinine results, and mpst of the speciineiis in question turned out to be icteric. Bilirubin, the m st troublesome interferent in the creatinine determination, is elevated (> 20 μιηοΐ/ΐ) in about 16% of our daily worklpad. It therefpre appeared expedient to study the state of the art of the Chem l analyser with respect to interference by bilirubin with the creatinine determination. We have already drawn attention to this interference in a previous publieation (3).
It was clear that in order to answer this question a reliable method was needed. From the literature it is known that high-performance liquid chromatography (HPLC) can be suitable analytical method.
High-performance liquid chromatography for the determination of creatinine in serum has been described, using both reversed-phase (5 -8) and ion exchange Systems (9) (10) (11) (12) .
However, almost all techniques described have a low throughput, either due to long column preconditioning or to gradient elution.
Furthermore the use of trichloroacetic acid, used in a number of techniques s a deproteinizing agent, is not free of risks. The risks are inclusion of creatinine and conversion of creatine to creatinine (4).
We therefore considered Ultrafiltration s an independent mearis pf deproteinization (13) . Deproteinization of serum by Ultrafiltration and subsequent direct analysis of the aqueous supernatant could offer a true advantage over the established methods that use trichloroacetic acid.
Materials and Methods

Materials
Reagenls
All Chemicals vvere at least reagent grade. Creatinine (> 99%), bilirubin, trichloroacetic acid (20%), acetic acid (100%), hydrochloric acid (37%), dimethylsulphoxide, sodium carbonate, methanol Lichrosolv and acetic acid, were obtained from Merck, Darmstadt, Germany. The concentration of trichloroâ cetic acid used was 0.6 mol/1 (10%). Lithium acetate dihydrate, MicroSelect, was obtained from Fluka BioChemika AG Buchs, Switzerland.
Creatinine iminohydrolase (EC 3.5.4.21) used for interference studies was obtained from Sigma, St Louis, MO, U. S. A.
Water was purified with the Milli-Q water System from Millipore, Molsheim, France.
A stock solution of 10 mmol/1 creatinine was prepared in 20 mmol/1 hydrochloric acid and was used to make seven aqueous Standard Solutions covering the r nge 50-1000 μιηοΐ/ΐ.
The serum samples were stored for up to one month at -80 °C until further use.
Standard reference material 909 from the National Institute of Standards and Technology, U. S. A. was used together with two levels (Kontrollogen-L and -LP) control sera from Behringwerke A. G., Marburg, Germany, to evaluate the HPLC method.
Furthermore, six reference sera (A, B, C, D, E, F) from the Deutsche Gesellschaft f r Klinische Chemie*, Zentrale Referenzinstitution were used s control material. In all sera the creatinine determination was performed by isotope dilution-mass spectrometry and by a validated reference method.
Methods
Ultrafiltration
The disposable Centrifree Micropartition System from Amicon used in a fixed-angle rotor (JA-21 Beckman) provides an ultrafiltrate which is almost free from protein after centrifugation at 1000#.
In the removal of protein from a serum sample by ultrafiltration, there is a decrease of the total sample volume due to the removal of proteins.
A factor of 0.9456 is used to adjust for this change in volume according to Weast (15) .
Sample preparation
A serum sample (100-300 μΐ) was centrifuged for 20 minutes and ΙΟμΙ ultrafiltrate was directly injected into the HPLC System.
Blank sample preparation
Serum (500 μΐ) was mixed with 50 μΐ Tris buffer containing 20 kU/1 creatinine iminohydrolase and incubated in a closed tube for 60 minutes at 37 °C.
Bilirubin interference
The protocol worked out by the Societe Fran^aise de Biologie Clinique was used to study interference by bilirubin (14) .
High performance liquid chromatography (HPLC)
The HPLC System from Spectra Physics consisted of a SP8800 HPLC pump, a SP8780 autosarnpler, a SP8790 column heater, a SP8450 UV detector and a SP4290 integrator. The HPLC procedure is essentially according to Kagedal & Olsson (l 1). , and the flow rate was 1.0 ml/min.
Beca se there was no dilution of the sample with trichloroacetic acid s in the original procedure, we preferred to reduce the injection volume from 20 to 10 μΐ in order to minimize peak broadening. The column teinperature was raised to 40 °C, in order to diminish peak tailing. The absorbance was monitored at 234 nm, and calibration was performed with aqueous external Standards.
Results
Preliminary experiments, performed exactly according to the procedure of Kagedal & Olssen with aqueous Standard material, occasionally showed a second peak or tailing peaks. We suspected trichloroacetic acid, because reductipn of the amount of trichloroacetic acid more or less solved this problem. We decided to study this phenomenon at a later stage and to circumvent the problem by applying the Amicon Centrifree Micropartition System, because this System had worked very well in initial experiments. This System provides aii almost protein-and bilirubin-free ultrafiltrate and requires only 100 μΐ of serum.
Because of this modificatiori we had to re-examine the precision, accuracy, linearity, sensitivity and recovery of the method.
Precision
Analytical imprecision was calculated from two commercially available human control sera with creatiniiie levels of 123.5 μπιοΐ/ΐ (Kontrollogen L) and 293 μηιοΐ/ΐ (Kontrollogen LP). Within-day imprecision was determined by six replicate analyses of Kontrollogen L and LP.
Between day imprecision was assessed using the same controls, divided into aliqu ts and stored at -20 °C. On 10 separate occasions an aliquot of each level was thawed and analysed. The results are shpwn in t ble l.
Accuracy
To evaluate the accuracy of the HPLC method, we analysed seven sera, the creatinine values of which o had been determined by isotope dilutions-mass spectrometry or by a reference mettyod (see tab. 2). For all sera the mean concentration of creatinine measured by HPLC was within 97.8% to 103.9% of the stated value.
Linearity
We used a calibration curve prepared from aqueous creatinine Standards covering the r nge 0 -1000 μιηοΐ/ΐ creatinine. A representative calibration curve is shown in figure 1 . The method proved to be linear up to 5000 μιηοΐ/ΐ, using an extended calibration set of 1500, 2000, 3000, 5000 μπιοΐ/ΐ.
Sensitivity
The sensitivity in terms of the differentiation of a peak from background noise was estimated to be 0.25 μπιοΐ/ΐ (three times the noise).
Recovery
Recovery of creatinine frpm the ultrafiltration System was checked by means of three aqueous creatinine Standards (125, 500 and 1000 μπιοΐ/ΐ). Furthermore we added an aqueous creatinine Standard (100 μηιοΐ/ΐ) to ten serum samples with different creatinine concentrations and the same Standard to ten serum samples with a creatinine level of about 90 μηιοΐ/ΐ (see tab. 3).
To be absolutely sure that the ultrafiltrate represents the true creatinine concentration of the sample, we also used the standard-addition technique to estimate the creatinine concentration of the two calibrators, Kontrollogen L and Kontrollogen LP, and the S. R. M. 909 of the National Institute of Standards and Technology.
Creatinine was added to a serum sample at a concentration of zero, once and twice the estimated creatinine concentration, Four HPLC analyses were performed on each sample.
The average area of these four analyses was used to calculate the linear regression line through these three points. The recovery of the additions was found to be 99.8% ± 0.5%.
The results are shown in table 4.
Interference by bilirubin
Conjugated and unconjugated bilirubin were investigated separately s possible sources of interference. The conjugated samples were taken from our daily workload, by measuring the total bilirubin level s well s the conjugated fraction with the Technicon Chemrl. The selected samples had a total bilirubin concentration of > 100 μιηοΐ/ΐ, r nge 102 -564 μιηοΐ/ΐ, mean 210 μιηοΐ/ΐ, the conjugated fraction being elevated, r nge 10-279 μιηοΐ/ΐ, mean 117 μηιοΙ/1. 100  165  167  100  268  342  100  442  375  100  474  172  100  273  137  100  237  249   201  100  300  166  100  264  305  100 serum was incubated with creatinine iininohydf olase, and an ultr filtrate was also analysed with the HPLC.
In npne of 100 samples did we find interfering peaks due to bilirubin or othef s bstaiices. An example is given in figure 2 , a serum sample with a total bilirubin concentration of 385 μηιοΐ/ΐ. 
Conjugated bilirubin
We analysed approximately 100 samples with the HPLC method and with the Chem l analyser, each sample being analysed twice. First an ultrafiltrate from the native serum was used to measure the creatinine concentration, next an aliquot of the same
Non-conjugated bilirubin
We investigated bilirubin added t serum, and added to an albumin/creatinine mixture, according to the CERMAB protocol (14) . The results revealed no interference from unconjugated bilirubin, s shown in figure 3 .
Apart from these samples, we studied samples from neonates. These samples (n = 15) were incubated with creatinine iminohydrolase. Again we found no interfering peak in any chromatogram.
Creatinine 
Discussion
In his review of the estimation of creatinine (16) Spencer mentioned the importance of the effect of bilirubin in kinetic Jaffe procedures. Furthermore, he said that HPLC methods are relatively quick for single estimations and that the between-day precision could be compared to most Jaffe procedures.
The weak cation exchange procedure of Kagedal & Olssen (11) , has introduced a new era of creatinine estimations. Interference studies showed no interference by uric acid, caffeine, xanthine and several drugs, but bilirubiii was not investigated. Because of the importance of creatinine concentration s a clinical Parameter and because of the negative interference of elev ted bilirubin concentrations we wondered whether the HPLC procedure could serve s an alternative for our routine method in emergency cases. However, the use of trichloroacetic acid also possibly causes interference, so we circumvented this problem by using an ultrafiltration step. A second advantage of the replacement of trichloroacetic acid by the Amicon ultrafiltration System is the elimination of all dilution Steps, and in our opinion this is the reason that our precision and recovery are somewhat better than reported by Kagedal & Olsson. Accuracy also proved to be good. Retention times for creatinine were reprodudble and unaffected by creatinine concentration and injection volume.
Treatment with creatinine iminohydrolase proved that the peak with a retention time of 5.80 minutes was solely due to the presence of creatinine.
Elev ted bilirubin levels did not once show interference with any sample after treatment with creatinine iminohydrolase.
Furthermore, co-elution of an interfering substance was not observed in any of the examined "normal" samples used in the initial experiments.
In conclusion, the use of HPLC in combination with a weak cation exchanger to determine creatinine in serum is in our view a very fast, easy to use and accurate back-up System for patient sera with elev ted bilirubin leVels. In general we feel that our method meets the Standard of a candidate reference method. We prefer the use of the Standard addition technique instead of applying a protein correlation factor. At the moment we are comparing both modifications, together with a determination of the water content (17) .
